Thinking of joining a study?

Register your interest

NCT05118035 | Completed | Cardiovascular Diseases


Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality
Sponsor:

National Defense Medical Center, Taiwan

Information provided by (Responsible Party):

Chin Lin

Brief Summary:

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.

Condition or disease

Cardiovascular Diseases

Intensity Care

Morality

Intervention/treatment

AI-enabled ECG-based Screening Tool

Phase

Not Applicable

Study Type : Interventional
Estimated Enrollment : 15965 participants
Masking : Single
Primary Purpose : Screening
Official Title : Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality: a Pragmatic Randomized Clinical Trial
Actual Study Start Date : December 15, 2021
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : December 31, 2022
Arm Intervention/treatment

Experimental: Intervention

Patients randomized to intervention will have access to the screening tool. Once the AI-ECG indicates high risk of mortality, a warning message would be immediately triggered and sent to the corresponding attending physicians. Notifications appear in the recipient's smartphone message system for the prompt attention. The message notified the physician that, "An ECG was received for patient X. An ECG indicates high risk of mortality. Please intensively attend to patient's conditions. If the physicians need to further identify the ECG, click on the following link to connect the ECG and the result of AI-ECG prediction." Of note, although we will actively send a warning message for high risk cases, the AI-ECG report for low risk cases still presented the degree of risk. Physicians can check the relative severity by access EHR for patients in the intervention group.

No Intervention: Control

Patients will continue routine practice.

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Patients in emergency department or inpatient department.
  • Patients recieved at least 1 ECG examination.
Exclusion Criteria
  • The patients recieved ECG at the period of inactive AI-ECG system.

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

Location Details


Please Choose a site



Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Taiwan,

National Defense Medical Center

Taipei, Taiwan, 114

Loading...